High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples

Main Article Content

Adrian A. Pater
Michael S. Bosmeny
Adam A. White
Rourke J. Sylvain
Seth B. Eddington
Mansi Parasrampuria
Katy N. Ovington
Paige E. Metz
Abadat O. Yinusa
Christopher L. Barkau
Ramadevi Chilamkurthy
Scott W. Benzinger
Madison M. Hebert
Keith T. Gagnon

Keywords

SARS-CoV-2, sequencing, nanopore, MinION, COVID-19, genome, mutations, protocol

Abstract

In late 2019, a novel coronavirus began spreading in Wuhan, China, causing a potentially lethal respiratory viral infection. By early 2020, the novel coronavirus, called SARS-CoV-2, had spread globally, causing the COVID-19 pandemic. The infection and mutation rates of SARS-CoV-2 make it amenable to tracking introduction, spread and evolution by viral genome sequencing. Efforts to develop effective public health policies, therapeutics, or vaccines to treat or prevent COVID-19 are also expected to benefit from tracking mutations of the SARS-CoV-2 virus. Here we describe a set of comprehensive working protocols, from viral RNA extraction to analysis using established visualization tools, for high throughput sequencing of SARS-CoV-2 viral genomes using a MinION instrument. This set of protocols should serve as a reliable "how-to" reference for generating quality SARS-CoV-2 genome sequences with ARTIC primer sets and long-read nanopore sequencing technology. In addition, many of the preparation, quality control, and analysis steps will be generally applicable to other sequencing platforms.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
Abstract 56 | HTML Downloads 280 PDF Downloads 185 Supplementary information Downloads 0

References

1. Daszak P, Keusch GT, Phelan AL, Johnson CK, Osterholm MT. Infectious Disease Threats: A Rebound To Resilience. Health Aff (Millwood). 2021 Feb;40(2):204–11. https://doi.org/10.1377/hlthaff.2020.01544 PMID:33476187
2. Grubaugh ND, Hodcroft EB, Fauver JR, Phelan AL, Cevik M. Public health actions to control new SARS-CoV-2 variants. Cell. 2021 Mar;184(5):1127–32.https://doi.org/10.1016/j.cell.2021.01.044 PMID:33581746
3. Gardy J, Loman NJ, Rambaut A. Real-time digital pathogen surveillance - the time is now. Genome Biol. 2015 Jul;16(1):155. https://doi.org/10.1186/s13059-015-0726-x PMID:27391693
4. Khudyakov Y. Molecular surveillance of hepatitis C. Antivir Ther. 2012;17 (7 Pt B):1465–70. https://doi.org/10.3851/IMP2476 PMID:23321496
5. McGinnis J, Laplante J, Shudt M, George KS. Next generation sequencing for whole genome analysis and surveillance of influenza A viruses. J Clin Virol. 2016 Jun;79:44-50. https://doi.org/10.1016/j.jcv.2016.03.005 PMID: 27085509
6. Houldcroft CJ, Beale MA, Breuer J. Clinical and biological insights from viral genome sequencing. Nat Rev Microbiol. 2017 Mar;15(3):183–92. https://doi.org/10.1038/nrmicro.2016.182 PMID:28090077
7. Thomson E, Ip CL, Badhan A, Christiansen MT, Adamson W, Ansari MA, et al. Comparison of Next-Generation Sequencing Technologies for Comprehensive Assessment of Full-Length Hepatitis C Viral Genomes. J Clin Microbiol. 2016 Oct;54(10):2470–84. https://doi.org/10.1128/JCM.00330-16 PMID:27385709
8. Quick J, Grubaugh ND, Pullan ST, Claro IM, Smith AD, Gangavarapu K, et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat Protoc. 2017 Jun;12(6):1261–76. https://doi.org/10.1038/nprot.2017.066 PMID:28538739
9. Tyson JR, et al. Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. bioRxiv : the preprint server for biology, (Sep 4, 2020).
10. Bull RA, Adikari TN, Ferguson JM, Hammond JM, Stevanovski I, Beukers AG, et al. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis. Nat Commun. 2020 Dec;11(1):6272. https://doi.org/10.1038/s41467-020-20075-6 PMID:33298935
11. Baker DJ, Aydin A, Le-Viet T, Kay GL, Rudder S, de Oliveira Martins L, et al. CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes. Genome Med. 2021 Feb;13(1):21. https://doi.org/10.1186/s13073-021-00839-5 PMID:33563320
12. Gohl DM, Garbe J, Grady P, Daniel J, Watson RH, Auch B, et al. A rapid, cost-effective tailed amplicon method for sequencing SARS-CoV-2. BMC Genomics. 2020 Dec;21(1):863. https://doi.org/10.1186/s12864-020-07283-6 PMID:33276717
13. Li J, Wang H, Mao L, Yu H, Yu X, Sun Z, et al. Rapid genomic characterization of SARS-CoV-2 viruses from clinical specimens using nanopore sequencing. Sci Rep. 2020 Oct;10(1):17492. https://doi.org/10.1038/s41598-020-74656-y PMID:33060796
14. Rambaut A, Holmes EC, O’Toole Á, Hill V, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020 Nov;5(11):1403–7. https://doi.org/10.1038/s41564-020-0770-5 PMID:32669681
15. Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018 Dec;34(23):4121–3. https://doi.org/10.1093/bioinformatics/bty407 PMID:29790939
16. Pastorino B, Touret F, Gilles M, Luciani L, de Lamballerie X, Charrel RN. Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples. Viruses. 2020 Jun;12(6):624. https://doi.org/10.3390/v12060624 PMID:32521706
17. Itokawa K, Sekizuka T, Hashino M, Tanaka R, Kuroda M. Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR. PLoS One. 2020 Sep;15(9):e0239403. https://doi.org/10.1371/journal.pone.0239403 PMID:32946527
18. Potapov V, Ong JL. Examining Sources of Error in PCR by Single-Molecule Sequencing. PLoS One. 2017 Jan;12(1):e0169774. https://doi.org/10.1371/journal.pone.0169774 PMID:28060945
19. Singer J, Gifford R, Cotten M, Robertson D. CoV-GLUE: A Web Application for Tracking SARS-CoV-2 Genomic Variation. Preprints. 18 Jun 2020. https://doi.org/10.20944/preprints202006.0225.v1